• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. STFX SPI PDS+ UNI VIO 9IN 0 S/A CT-1; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. STFX SPI PDS+ UNI VIO 9IN 0 S/A CT-1; SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID Back to Search Results
Catalog Number SXPP1B455
Device Problem Positioning Problem (3009)
Patient Problems Wound Dehiscence (1154); Adhesion(s) (1695)
Event Date 02/06/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.What was the date of the initial procedure? what tissue type and location of the suture placement? what was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? where did the suture start (top to bottom or bottom to top)? when suturing with stratafix symmetric, how far was the bite from the edge of the tissue? were any solutions used during closure (ie antimicrobial)? what date post op did the patient experience adhesions? how were the adhesions from the cuff to the bladder diagnosed? was a second procedure or surgical intervention performed? on what date was the second procedure? can you describe the appearance of the suture during the second procedure? was the suture intact and pulled through the tissue? do you have the status of suture for evaluation? did the operating surgeon observe any suture deficiency or anomaly before or during the suture placement? what is the patient age, weight, relevant patient history/concomitant medications? what is physician¿s opinion as to the etiology of or contributing factors to this event? what is the surgeon opinion as to the relationship of the stratafix suture to the adhesions? what is the patient current status?.
 
Event Description
It was reported that the patient underwent hysterectomy on an unknown date and barbed suture was used.Post-op of the procedure, the patient experienced adhesions from the cuff to the bladder.It was reported that the patient experienced dehiscence.Additional information has been requested.
 
Manufacturer Narrative
(b)(4).Additional information was requested and the following was obtained: what was the date of the initial procedure? unknown.What tissue type and location of the suture placement? vaginal cuff.What was the tissue condition, i.E., normal or thin, calcified, fragile, diseased? unknown.Where did the suture start (top to bottom or bottom to top)? unknown.When suturing with stratafix symmetric, how far was the bite from the edge of the tissue? unknown.Were any solutions used during closure (ie antimicrobial)? unknown.What date post op did the patient experience adhesions? unknown.How were the adhesions from the cuff to the bladder diagnosed? unknown ,reported to the hospital by the surgeon.Was a second procedure or surgical intervention performed? unknown.On what date was the second procedure? can you describe the appearance of the suture during the second procedure? no rep was present.Was the suture intact and pulled through the tissue? not reported.Do you have the status of suture for evaluation? no.Did the operating surgeon observe any suture deficiency or anomaly before or during the suture placement? no.What is the patient age, weight, relevant patient historyconcomitant medications? not reported.What is physician¿s opinion as to the etiology of or contributing factors to this event? he was uncertain , did not know if it was related to the suture.What is the surgeon opinion as to the relationship of the stratafix suture to the adhesions? he was uncertain if there was a relationship and has used stratafix again.What is the patient current status? according to the surgeon the patient is doing fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STFX SPI PDS+ UNI VIO 9IN 0 S/A CT-1
Type of Device
SUTURE, ABSORBABLE, SYNTHETIC, POLYGLYCOLIC ACID
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8392328
MDR Text Key137883098
Report Number2210968-2019-79271
Device Sequence Number1
Product Code NEW
UDI-Device Identifier10705031240834
UDI-Public10705031240834
Combination Product (y/n)N
PMA/PMN Number
K150670
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSXPP1B455
Was Device Available for Evaluation? No
Date Manufacturer Received03/11/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-